Investing.com - Kalvista Pharma reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Kalvista Pharma announced earnings per share of $-0.94 on revenue of $0.00. Analysts polled by Investing.com EPS of $-1.04 on revenue of $0.00.
Kalvista Pharma 's are up 20% and is trading at $15.92 , still down 26.86% from its 52 week high of $21.76 set on Friday, September 10, 2021.
Kalvista Pharma shares gained 1.73% to trade at $15.92 in intra-day trade the report.
Kalvista Pharma follows other major Healthcare sector earnings this month
Kalvista Pharma's report follows an earnings beat by Medtronic on Tuesday, August 23, 2022, who reported EPS of $1.13 on revenue of $7.37B, EPS of $1.12 on revenue of $7.22B.
Agilent Technologies had beat expectations on Tuesday, August 16, 2022 with third quarter EPS of $1.34 on revenue of $1.72B, for EPS of $1.2 on revenue of $1.64B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar